Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies.

Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D, Thompson A, Gudnason V, Sattar N, Danesh J.

Circulation. 2009 Dec 1;120(22):2177-87. doi: 10.1161/CIRCULATIONAHA.109.884866. Epub 2009 Nov 16. Review.

PMID:
19917883
[PubMed - indexed for MEDLINE]
Free Article
2.

N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.

Doi Y, Ninomiya T, Hata J, Hirakawa Y, Mukai N, Ikeda F, Fukuhara M, Iwase M, Kiyohara Y.

Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2997-3003. doi: 10.1161/ATVBAHA.111.223669. Epub 2011 Sep 15.

PMID:
21921261
[PubMed - indexed for MEDLINE]
Free Article
3.

Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies.

Karthikeyan G, Moncur RA, Levine O, Heels-Ansdell D, Chan MT, Alonso-Coello P, Yusuf S, Sessler D, Villar JC, Berwanger O, McQueen M, Mathew A, Hill S, Gibson S, Berry C, Yeh HM, Devereaux PJ.

J Am Coll Cardiol. 2009 Oct 20;54(17):1599-606. doi: 10.1016/j.jacc.2009.06.028. Review.

PMID:
19833258
[PubMed - indexed for MEDLINE]
Free Article
4.

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.

Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P.

JAMA. 2005 Apr 6;293(13):1609-16.

PMID:
15811980
[PubMed - indexed for MEDLINE]
5.

N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK).

Astor BC, Yi S, Hiremath L, Corbin T, Pogue V, Wilkening B, Peterson G, Lewis J, Lash JP, Van Lente F, Gassman J, Wang X, Bakris G, Appel LJ, Contreras G.

Circulation. 2008 Apr 1;117(13):1685-92. doi: 10.1161/CIRCULATIONAHA.107.724187. Epub 2008 Mar 24.

PMID:
18362234
[PubMed - indexed for MEDLINE]
Free Article
6.

Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.

Ryding AD, Kumar S, Worthington AM, Burgess D.

Anesthesiology. 2009 Aug;111(2):311-9. doi: 10.1097/ALN.0b013e3181aaeb11. Review.

PMID:
19602961
[PubMed - indexed for MEDLINE]
Free Article
7.

Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.

Moertl D, Berger R, Struck J, Gleiss A, Hammer A, Morgenthaler NG, Bergmann A, Huelsmann M, Pacher R.

J Am Coll Cardiol. 2009 May 12;53(19):1783-90. doi: 10.1016/j.jacc.2009.01.057.

PMID:
19422985
[PubMed - indexed for MEDLINE]
Free Article
8.

Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients.

Shadman R, Allison MA, Criqui MH.

J Am Coll Cardiol. 2007 Jun 5;49(22):2172-81. Epub 2007 May 18.

PMID:
17543637
[PubMed - indexed for MEDLINE]
Free Article
9.

Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.

Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L.

Clin Biochem. 2006 Jun;39(6):640-5. Epub 2006 Mar 3.

PMID:
16516185
[PubMed - indexed for MEDLINE]
10.

Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.

Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E; PEACE Investigators.

J Am Coll Cardiol. 2007 Jul 17;50(3):205-14. Epub 2007 Jun 29.

PMID:
17631211
[PubMed - indexed for MEDLINE]
Free Article
11.

Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.

Lam CS, Burnett JC Jr, Costello-Boerrigter L, Rodeheffer RJ, Redfield MM.

J Am Coll Cardiol. 2007 Mar 20;49(11):1193-202. Epub 2007 Mar 6.

PMID:
17367664
[PubMed - indexed for MEDLINE]
Free Article
12.

Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.

Kremastinos DT, Hamodraka E, Parissis J, Tsiapras D, Dima K, Maisel A.

Am Heart J. 2010 Jan;159(1):68-74. doi: 10.1016/j.ahj.2009.10.025.

PMID:
20102869
[PubMed - indexed for MEDLINE]
13.

N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.

Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, Lui SF, Sanderson JE.

J Am Soc Nephrol. 2007 Jan;18(1):321-30. Epub 2006 Dec 13.

PMID:
17167121
[PubMed - indexed for MEDLINE]
Free Article
14.

Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality.

Oluleye OW, Folsom AR, Nambi V, Lutsey PL, Ballantyne CM; ARIC Study Investigators.

Ann Epidemiol. 2013 Feb;23(2):66-73. doi: 10.1016/j.annepidem.2012.11.004. Epub 2012 Dec 8.

PMID:
23228375
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.

Eggers KM, Venge P, Lind L.

Am J Cardiol. 2013 Jan 1;111(1):131-6. doi: 10.1016/j.amjcard.2012.08.058. Epub 2012 Oct 2.

PMID:
23040598
[PubMed - indexed for MEDLINE]
16.

Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.

van Hateren KJ, Alkhalaf A, Kleefstra N, Groenier KH, de Jong PE, de Zeeuw D, Gans RO, Struck J, Bilo HJ, Gansevoort RT, Bakker SJ.

Clin Chem. 2012 Jan;58(1):293-7. doi: 10.1373/clinchem.2011.166348. Epub 2011 Sep 26.

PMID:
21948291
[PubMed - indexed for MEDLINE]
Free Article
17.

Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

Henriksen JH, Gøtze JP, Fuglsang S, Christensen E, Bendtsen F, Møller S.

Gut. 2003 Oct;52(10):1511-7.

PMID:
12970147
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Mid-regional pro-atrial natriuretic peptide levels in the elderly: clinical and prognostic implications, and comparison to B-type natriuretic peptides.

Eggers KM, Venge P, Lind L.

Clin Chim Acta. 2013 Apr 18;419:62-6. doi: 10.1016/j.cca.2013.01.020. Epub 2013 Feb 13.

PMID:
23415698
[PubMed - indexed for MEDLINE]
19.

A cross sectional study comparing traditional risk factors with N-terminal pro-BNP in high risk groups for cardiovascular disease in Trinidad, West Indies.

Shivananda Nayak B, Teelucksingh S, Jagessar A, Maharaj S, Maharaj N.

Diabetes Metab Syndr. 2013 Jan-Mar;7(1):8-11. doi: 10.1016/j.dsx.2013.02.021. Epub 2013 Mar 7.

PMID:
23517788
[PubMed - indexed for MEDLINE]
20.

Comparison of B-type natriuretic peptide and NT proBNP as predictors of survival in patients on high-flux hemodialysis and hemodiafiltration.

Sivalingam M, Suresh M, Farrington K.

Hemodial Int. 2011 Jul;15(3):359-65. doi: 10.1111/j.1542-4758.2011.00557.x. Epub 2011 May 31.

PMID:
21624043
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk